Related Experiment Video
Updated: May 29, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Dietary protein source mediates colitis pathogenesis through bacterial modulation of bile acids
Simon M Gray1, Michael C Wood2, Samantha C Mulkeen2
1Center for Gastrointestinal Biology and Disease, Department of Medicine, University of North Carolina, Chapel Hill, NC.
Switching from red meat protein to plant-based protein may reduce gut inflammation in inflammatory bowel diseases (IBD). Beef protein worsened colitis in mice, while pea protein had milder effects, suggesting protein source impacts gut health.
Area of Science:
- Microbiology
- Gastroenterology
- Immunology
Background:
- Dietary recommendations for inflammatory bowel diseases (IBD) are limited.
- Red meat consumption is linked to increased IBD incidence and relapse.
- Plant-based diets may mitigate gut inflammation, but underlying mechanisms are unclear.
Purpose of the Study:
- To investigate the differential effects of plant- vs. animal-derived proteins on gut inflammation.
- To elucidate the mechanisms by which beef protein promotes colitis in a murine model.
Main Methods:
- Murine colitis models were fed diets with beef protein (BP) or pea protein (PP).
- Microbiota manipulation (depletion, transplantation) was used to assess microbial mediation.
- Fecal bile acid (BA) profiles and mucus layer integrity were analyzed.
- The impact of psyllium supplementation was evaluated.
Main Results:
- BP-fed mice exhibited severe colitis, while PP-fed mice showed mild inflammation.
- BP-induced colitis was microbially-mediated.
- BP feeding altered gut microbiota composition and reduced mucus layer quality.
- Elevated fecal bile acids were observed in BP-fed mice, and taurocholic acid exacerbated colitis.
- Psyllium protected against BP-mediated inflammation and normalized BA profiles.
Conclusions:
- The protein component of red meat may contribute to colitis promotion.
- Microbial and bile acid alterations are key mechanisms in BP-induced gut inflammation.
- Dietary interventions like psyllium may offer therapeutic potential for IBD by modulating gut environment.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Lipid Digestion